Citius Oncology, Inc. (CTOR) income statement
CTORNasdaqPharmaceutical PreparationsFiscal year ends September 30
$0.56+0.01 (+1.79%)
Close on Nov 18, 2026Market cap $51.83MP/E –Yield –
Citius Oncology, Inc. financial ratios
See a number that looks wrong?